Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LaFleur Minerals Provides Update on Beacon Mill Restart and Exploration Updates (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lancaster Resources Inc C.LCR

Alternate Symbol(s):  LANRF

Metals & Mining Gold
Lancaster Resources Inc. is a Canada-based company engaged in exploring lithium and uranium and other critical minerals. The Company’s Alkali Flat Lithium Project, which covers approximately 5,200 acres in Lordsburg, New Mexico, United States, and is involved in the exploration of a below-surface lithium brine target. The Company holds a 100% interest in the Catley Lalk and Centennial East... see more

Recent & Breaking News (CSE:LCR)

CSE Bulletin: Fundamental Change - NeonMind Biosciences Inc./Lancaster Resources Inc.

Newsfile June 13, 2023

CSE Bulletin: Consolidation - NeonMind Biosciences Inc. (NEON)

Newsfile March 2, 2023

IIROC Trading Halt - NEON

Canada NewsWire December 14, 2022

The New Digital Platform for Ketamine Treatments

Stockhouse Editorial April 25, 2022

NeonMind To Improve Patient Care and Data Management by Adopting Digital Platform for Ketamine Treatments in Preparation of Opening Its Inaugural Specialty Mental Health Clinic

ACCESS Newswire April 21, 2022

NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic

ACCESS Newswire April 19, 2022

CSE Bulletin: Consolidation - NeonMind Biosciences Inc. (NEON)

Newsfile April 14, 2022

NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows

ACCESS Newswire April 12, 2022

NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows

Canadian Press, with file by Stockhouse April 12, 2022

NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga

ACCESS Newswire March 23, 2022

NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects

ACCESS Newswire March 23, 2022

NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss

ACCESS Newswire March 22, 2022

NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments

ACCESS Newswire March 10, 2022

NeonMind and BioScript Solutions Announce Strategic Partnership Expanding NeonMind's Specialty Clinic Network for Interventional Psychiatry Treatments

ACCESS Newswire March 3, 2022

NeonMind Appoints Emergency and Addiction Expert Dr. Dinesh Bhayana, as Site Medical Director of its Inaugural Specialty Mental Health Clinic

ACCESS Newswire February 23, 2022

NeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, Ontario

ACCESS Newswire February 17, 2022

NeonMind Appoints Canadian Medical Leader in Anesthesiology, Dr. Daniel Bainbridge, MD, FRCPC to Its Specialty Clinics Advisory Board

ACCESS Newswire January 13, 2022

NeonMind to Present at H.C. Wainwright Bioconnect Conference

ACCESS Newswire January 6, 2022

NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

ACCESS Newswire December 2, 2021

NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001

ACCESS Newswire November 23, 2021